SAN CARLOS, Calif.-- October 14, 2026 -- Altay Therapeutics, Inc., a biotechnology company developing novel small molecule inhibitors of transcription factors, today announced the completion of a $37 million Series...
Arthur Klausner to speak at "NC Early-Stage Breakfast" in Raleigh, NC.
News | 11. 14. 2007
